Literature DB >> 17577295

A global survey of physicians' perceptions on cholesterol management: the From The Heart study.

L R Erhardt1, F D R Hobbs.   

Abstract

AIMS: Guidelines for cardiovascular disease (CVD) prevention cite high levels of low-density lipoprotein cholesterol (LDL-C) as a major risk factor and recommend LDL-C goals for various risk groups. Lifestyle changes are advised as first-line treatment for patients with high cholesterol, and statins are recommended in high-risk patients. The From The Heart study investigated current practice for the diagnosis and treatment of high cholesterol, and attitudes towards management of the condition.
METHODS: Physicians were randomly selected from 10 countries, and completed a confidential, semi-structured questionnaire.
RESULTS: Of 2790 physicians agreeing to participate, 750 (27%) responded. Physicians rated CVD as the leading cause of death, although physicians (80%) perceived that cancer was the most feared illness among patients. Physicians (71%) believed smoking to be the greatest CVD risk factor, while only 50% thought high cholesterol was the greatest risk. Most physicians (81%) used guidelines to set cholesterol goals, primarily their national guidelines (34%) or the National Cholesterol Education Program Adult Treatment Panel III guidelines (24%). Although only 47% of patients reached and maintained their cholesterol goals, 61% of physicians believed that a sufficient number of patients achieved goals, and 53% did not feel frustrated that they could not always effectively treat patients with CVD.
CONCLUSION: Results indicate discrepancies between guideline recommendations and clinical practice. Although physicians appreciate the risk of CVD, the importance of achieving healthy cholesterol levels for CVD prevention does not seem to be widely endorsed. There is a need for improved communication regarding the importance of cholesterol lowering and investigation of initiatives to improve goal achievement among physicians.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577295     DOI: 10.1111/j.1742-1241.2007.01420.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

1.  High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries.

Authors:  Gregory A Roth; Stephan D Fihn; Ali H Mokdad; Wichai Aekplakorn; Toshihiko Hasegawa; Stephen S Lim
Journal:  Bull World Health Organ       Date:  2010-09-03       Impact factor: 9.408

2.  Lipid-lowering drugs as primary prevention in general practice: do patients reach guideline goals and continue treatment? ADDITION Denmark.

Authors:  Lise Graversen; Bo Christensen; Knut Borch-Johnsen; Torsten Lauritzen; Annelli Sandbaek
Journal:  Scand J Prim Health Care       Date:  2011-12       Impact factor: 2.581

3.  General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark.

Authors:  Lise Graversen; Bo Christensen; Knut Borch-Johnsen; Torsten Lauritzen; Annelli Sandbaek
Journal:  Scand J Prim Health Care       Date:  2010-03       Impact factor: 2.581

4.  Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA).

Authors:  Fernando Rodríguez-Artalejo; Eliseo Guallar; Claudio Borghi; Jean Dallongeville; Guy De Backer; Julian P Halcox; Ramón Hernández-Vecino; Francisco Javier Jiménez; Elvira L Massó-González; Joep Perk; Philippe Gabriel Steg; José R Banegas
Journal:  BMC Public Health       Date:  2010-06-30       Impact factor: 3.295

5.  Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.

Authors:  Roland E Schmieder; Matthias Goebel; Peter Bramlage
Journal:  Vasc Health Risk Manag       Date:  2012-03-15

6.  Awareness, knowledge and practice of dyslipidaemia management among postgraduate primary care trainees in Malaysia: a cross-sectional study.

Authors:  Abdul Hadi Said; Yook Chin Chia
Journal:  BMJ Open       Date:  2017-03-01       Impact factor: 2.692

7.  Mixed methods evaluation of targeted case finding for cardiovascular disease prevention using a stepped wedged cluster RCT.

Authors:  Tom Marshall; Michael Caley; Karla Hemming; Paramjit Gill; Nicola Gale; Kate Jolly
Journal:  BMC Public Health       Date:  2012-10-26       Impact factor: 3.295

8.  A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile.

Authors:  J S Benner; L Erhardt; M Flammer; R A Moller; N Rajicic; K Changela; C Yunis; S B Cherry; Z Gaciong; E S Johnson; M C J M Sturkenboom; J García-Puig; X Girerd
Journal:  Int J Clin Pract       Date:  2008-08-07       Impact factor: 2.503

9.  Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL-C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study.

Authors:  Rongjing Ding; Ping Ye; Shuiping Zhao; Dong Zhao; Xiaowei Yan; Yugang Dong; Jihu Li; Yuqin Ran; Dayi Hu
Journal:  J Glob Health       Date:  2017-12       Impact factor: 4.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.